Publication Author: Sullivan_Sean

• Estimating the cost-effectiveness of onabotulinumtoxinA for neurogenic detrusor overactivity in the United States.

  Carlson JJ, Hansen RN, Dmochowski RR, Globe DR, Colayco DC, Sullivan SD. Estimating the Cost-Effectiveness of OnabotulinumtoxinA for Neurogenic Detrusor Overactivity in the United States. Clin Ther. 2013 Apr;35(4):414-24. doi: 10.1016/j.clinthera.2013.02.

  rakerr2

  April 1, 2013

• Economic consequences of sequencing biologics in rheumatoid arthritis: a systematic review.

  Sullivan SD, Alfonso-Cristancho R, Carlson J, Mallya U, Ringold S. Economic consequences of sequencing biologics in rheumatoid arthritis: a systematic review. J Med Econ. 2013;16(3):391-6. doi: 10.3111/13696998.2013.763812. Epub 2013 Jan 18.

  rakerr2

  January 18, 2013

• Methotrexate and injectable tumor necrosis factor-α inhibitor adherence and persistence in children with rheumatic diseases.

  Ringold S, Grant S, Girdish C, Wallace CA, Sullivan SD. Methotrexate and injectable tumor necrosis factor-α inhibitor adherence and persistence in children with rheumatic diseases. J Rheumatol. 2013 Jan;40(1):80-6. doi: 10.3899/jrheum.120753. Epub 2012 No

  rakerr2

  January 1, 2013

• Cost-effectiveness of distributing naloxone to heroin users for lay overdose reversal.

  Coffin PO, Sullivan SD. Cost-effectiveness of distributing naloxone to heroin users for lay overdose reversal. Ann Intern Med. 2013 Jan 1;158(1):1-9. doi: 10.7326/0003-4819-158-1-201301010-00003.

  rakerr2

  January 1, 2013

• Comparative effectiveness research in the United States: a progress report.

  Sullivan SD, Carlson JJ, Hansen RN. Comparative effectiveness research in the United States: a progress report. J Med Econ. 2013;16(2):295-7. doi: 10.3111/13696998.2012.754613. Epub 2012 Dec 11.

  rakerr2

  December 11, 2012

• Measuring Alzheimer disease progression with transition probabilities: estimates from NACC-UDS.

  Spackman DE, Kadiyala S, Neumann PJ, Veenstra DL, Sullivan SD. Measuring Alzheimer disease progression with transition probabilities: estimates from NACC-UDS. Curr Alzheimer Res. 2012 Nov;9(9):1050-8.

  rakerr2

  November 1, 2012

• Associations of patient outcomes with level of asthma control.

  Gold LS, Smith N, Allen-Ramey FC, Nathan RA, Sullivan SD. Associations of patient outcomes with level of asthma control. Ann Allergy Asthma Immunol. 2012 Oct;109(4):260-265.e2. doi: 10.1016/j.anai.2012.07.024. Epub 2012 Aug 15.

  rakerr2

  October 1, 2012

• BMI trajectories among the severely obese: results from an electronic medical record population.

  Wong ES, Wang BC, Alfonso-Cristancho R, Flum DR, Sullivan SD, Garrison LP, Arterburn DE. BMI trajectories among the severely obese: results from an electronic medical record population. Obesity (Silver Spring). 2012 Oct;20(10):2107-12. doi: 10.1038/oby.20

  rakerr2

  October 1, 2012

• Utilization and costs of health care after geriatric traumatic brain injury.

  Thompson HJ, Weir S, Rivara FP, Wang J, Sullivan SD, Salkever D, MacKenzie EJ. Utilization and costs of health care after geriatric traumatic brain injury. J Neurotrauma. 2012 Jul 1;29(10):1864-71. doi: 10.1089/neu.2011.2284. Epub 2012 Apr 26.

  rakerr2

  July 1, 2012

• Study protocol: the Back Pain Outcomes using Longitudinal Data (BOLD) registry.

  Jarvik JG, Comstock BA, Bresnahan BW, Nedeljkovic SS, Nerenz DR, Bauer Z, Avins AL, James K, Turner JA, Heagerty P, Kessler L, Friedly JL, Sullivan SD, Deyo RA. Study protocol: the Back Pain Outcomes using Longitudinal Data (BOLD) registry. BMC Musculoske

  rakerr2

  May 3, 2012